Search PubMed⌕ Search

Biomedical subjects

E D White

Publications and source records attributed to E D White.

7 recordsLinked to original sources
PubMed2001

Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.

Sulfhydryl-2 domain-containing tyrosine phosphatase-1 (SHP-1) has an important role in the negative regulation of many receptors including the interleukin (IL)-4 receptor. Motheaten mice (me/me) have a homozygous mutation in SHP-1 and do not possess functional SHP-1. Pre-B-cell lines derived from me/me mice have been reported to display prolonged IL-4-dependent activation of signal transducer and activator of transcription-6 (Stat6). We evaluated IL-4-dependent Stat6 activation and Fcepsilon receptor 1 (FcepsilonRI) modulation in bone marrow-derived mast cells (BMMCs) from me/me and wild-type mice. IL-4 down-regulated FcepsilonRI expression in wild-type BMMCs but had no effect on FcepsilonRI expression in me/me BMMCS: Furthermore, me/me mast cells did not exhibit enhanced or prolonged IL-4-induced Stat6 activation compared with wild-type cells, indicating that mast cells possess alternative tyrosine phosphatases that are responsible for down-regulating Stat6 or can substitute for SHP-1. Thus, SHP-1 is not a negative regulator of IL-4 signaling in BMMCS: These results demonstrate the complexity and cellular specificity of these signaling pathways and indicate a previously unrecognized role for SHP-1 in murine mast cells.

Animals↗
PubMed1997

Minimum sample sizes for identifying chromosomal fragile sites from individuals: Monte Carlo estimation.

A Monte Carlo simulation procedure was used to estimate the exact level of the standardized X2 test statistic (Xs2) for randomness in the FSM methodology for the identification of fragile sites from chromosomal breakage data for single individuals. A random-number generator was used to simulate 10,000 chromosomal breakage data sets, each corresponding to the null hypothesis of no fragile sites for numbers of chromosomal breaks (n) from 1 to 2000 and at three levels of chromosomal band resolution (k). The reliability of the test was assessed by comparisons of the empirical and nominal alpha levels for each of the corresponding values of n and k. These analyses indicate that the sparse and discrete nature of chromosomal breakage data results in large and unpredictable discrepancies between the empirical and nominal alpha levels when fragile site identifications are based on small numbers of breaks (n < 0.5 k). With n > or = 0.5 k, the distribution of Xs2 appears to be stable and non-significant differences in the empirical and nominal alpha levels are generally obtained. These results are inherent to the nature of the data and are, therefore, relevant to any statistical model for the identification of fragile sites from chromosomal breakage data. For FSM identification of fragile sites at alpha = 0.05, we suggest that n > or = 0.5 k is the minimum reliable number of mapped chromosomal breaks per individual.

Chromosome Fragile Sites↗
PubMedDate not supplied

Student perceptions of clinical mistreatment.

This study examined radiography students' perceptions regarding mistreatment during the clinical portion of their education. Results suggest that a majority of students perceived mistreatment and that second-year students were 4 times more likely to perceive mistreatment than first-year students. Most students who perceived mistreatment indicated that the abuse was verbal and came primarily from staff technologists. Most perceived the mistreatment to be slightly important and slightly upsetting. However, approximately one third perceived the mistreatment to be very important and very upsetting. As part of the study, students were asked to suggest preventive measures that could help eradicate abusive behavior in the clinical setting.

Adolescent↗